BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 19301648)

  • 1. The therapeutic potential of LNA-modified siRNAs: reduction of off-target effects by chemical modification of the siRNA sequence.
    Fluiter K; Mook OR; Baas F
    Methods Mol Biol; 2009; 487():189-203. PubMed ID: 19301648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality.
    Elmén J; Thonberg H; Ljungberg K; Frieden M; Westergaard M; Xu Y; Wahren B; Liang Z; Ørum H; Koch T; Wahlestedt C
    Nucleic Acids Res; 2005; 33(1):439-47. PubMed ID: 15653644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small interfering RNA for experimental cancer therapy.
    Tong AW; Zhang YA; Nemunaitis J
    Curr Opin Mol Ther; 2005 Apr; 7(2):114-24. PubMed ID: 15844618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA-based approaches in cancer therapy.
    Devi GR
    Cancer Gene Ther; 2006 Sep; 13(9):819-29. PubMed ID: 16424918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. siRNA delivery systems for cancer treatment.
    Oh YK; Park TG
    Adv Drug Deliv Rev; 2009 Aug; 61(10):850-62. PubMed ID: 19422869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LNA-antisense rivals siRNA for gene silencing.
    Jepsen JS; Wengel J
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):188-94. PubMed ID: 15603252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring chemical modifications for siRNA therapeutics: a structural and functional outlook.
    Shukla S; Sumaria CS; Pradeepkumar PI
    ChemMedChem; 2010 Mar; 5(3):328-49. PubMed ID: 20043313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in RNA sensing by the immune system: separation of siRNA unwanted effects from RNA interference.
    Sioud M
    Methods Mol Biol; 2010; 629():33-52. PubMed ID: 20387141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering the code of innate immunity recognition of siRNAs.
    Sioud M
    Methods Mol Biol; 2009; 487():41-59. PubMed ID: 19301641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical modification of siRNA.
    Chernolovskaya EL; Zenkova MA
    Curr Opin Mol Ther; 2010 Apr; 12(2):158-67. PubMed ID: 20373259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short interfering RNA (siRNA): tool or therapeutic?
    Cejka D; Losert D; Wacheck V
    Clin Sci (Lond); 2006 Jan; 110(1):47-58. PubMed ID: 16336204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The utility of LNA in microRNA-based cancer diagnostics and therapeutics.
    Stenvang J; Silahtaroglu AN; Lindow M; Elmen J; Kauppinen S
    Semin Cancer Biol; 2008 Apr; 18(2):89-102. PubMed ID: 18295505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in small interfering RNA sensing by the immune system.
    Sioud M
    N Biotechnol; 2010 Jul; 27(3):236-42. PubMed ID: 20219711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonviral in vivo delivery of therapeutic small interfering RNAs.
    Aigner A
    Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LNA incorporated siRNAs exhibit lower off-target effects compared to 2'-OMethoxy in cell phenotypic assays and microarray analysis.
    Puri N; Wang X; Varma R; Burnett C; Beauchamp L; Batten DM; Young M; Sule V; Latham K; Sendera T; Echeverri C; Sachse C; Magdaleno S
    Nucleic Acids Symp Ser (Oxf); 2008; (52):25-6. PubMed ID: 18776235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical modification of gene silencing oligonucleotides for drug discovery and development.
    Chen X; Dudgeon N; Shen L; Wang JH
    Drug Discov Today; 2005 Apr; 10(8):587-93. PubMed ID: 15837602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference in vivo: toward synthetic small inhibitory RNA-based therapeutics.
    de Fougerolles A; Manoharan M; Meyers R; Vornlocher HP
    Methods Enzymol; 2005; 392():278-96. PubMed ID: 15644187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic applications of RNAi for silencing virus replication.
    Tripp RA; Tompkins SM
    Methods Mol Biol; 2009; 555():43-61. PubMed ID: 19495687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of locked nucleic acid-modified small interfering RNA in vitro and in vivo.
    Mook OR; Baas F; de Wissel MB; Fluiter K
    Mol Cancer Ther; 2007 Mar; 6(3):833-43. PubMed ID: 17363479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [RNA interference and molecular pathology of selected diseases].
    Lochmanová J; Bartos M
    Cas Lek Cesk; 2008; 147(12):607-15. PubMed ID: 19235485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.